Untersuchung von nierentransplantierten Patienten unter Berücksichtigung der HLA-Kompatibilität und der Dynamk der HLA-AntikörperbildungWolf-Adam Seeger11234522.162.27892.32.3.12.3.1.1102.3.1.211122.3.22.4132.5141533.13.1.11516624#508173.1.218192021623#509223.1.323242526624#509273.1.428293.1.53031623#508323.1.63334623#509353.23.2.136623#553373.2.238623#508393.340624#50941423.4433.544454647484484950515253545555556AbkürzungenLiteraturverzeichnisErklärung an Eides StattLebenslaufDanksagungdeInhaltsverzeichnisHilfe Literaturverzeichnis 1.Kirste, G.: Stand und Entwicklung der Nierentransplantation
Zentralbl Chir 118: 113-117 (1993) 2.May, G.: Gegenwart und Perspektiven der Nierentransplantation
Z-Gesamte-Inn-Med 41: 294-297 (1986) 3.Lütkes, P., Franke, G., Witzke, O., Zimmermann, U., Kohnle, M., Philipp, T., Heemann, U.: Lebensqualität nach Nierentransplantation. Einfluß neuer immunsuppressiver Maßnahmen.Zentralbl-Chir. 124: 90-94 (1999) 4.Christensen, A.J., Holman Jr., J.M., Turner, C.W., Smith, T.W., Grant, M.K., DeVault Jr., G.A.: A Prospective Study of Quality of Life in End-Stage Renal Disease: Effects of Cadaveric Renal TransplantationClin. Transplantation 5: 40-47 (1991) 5.Linker, H.:, Langzeitprognose nach NierentransplantationVersicherungsmedizin 51: 69-70 (1999) 6.Yoshimura,. , Oka , T., Nakane, Y., Aikawa, I., Okamoto, M., Akioka, K., Nakamura, K., Ushigome, H., Kadotani,., Ohmori, Y.: Long-Term Results and Complications of Living Related Kidney Transplantation in a Single CenterTransplant-Proc. 34: 1675-1677 (2002) 7. Howard, R.J., Reed, A.I., Hemming, A.W., Van der Werf, W.J., Patton, P.R., Pfaff, W.W., Srinivas, T.R., Scornik, J.C.: Graft Loss and Death: Changing Causes After Kidney Transplantation
Transplant-Proc 33: 3416 (2001) 8.Tan, B.H.: Infections in Transplant Recipients in Developing CountriesTransplant-Proc. 32: 1501-1502 (2000) 9.Ossareh, S., Ghods, A.J.: Results of Renal Transplantation in the Elderly: Single Center ExperienceTransplant-Proc. 34: 2068-2069 (2002) 10.Frei, U., Schindler, R.: Probleme im Langzeitverlauf nach Nierentransplantation.
Internist 36: 263-269 (1995) 11.Ivens, K., Aker, S., Grabensee, B., Heering, P.: Inzidenz von Risikofaktoren und kardiovaskulären Komplikationen bei Patienten nach Nierentransplantation
Med-Klin. 94: 478-84 (1999) 12.Schindler, R., Schneider, U., Frei, U.: Die kardiale Situation des Nierentransplantierten
Nieren- und Hochdruckkrankheiten29: 440-444 (2000) 13.Fabrega, A., Matas, A.J., Payne, W.D., Fryd, D.S., Dunn, D.L., Sutherland, D.E.R., Najarian, J.S .: Ten- to 20-year follow-up of 123 consecutive HLA-identical living-related kidney transplants from the pre-cyclosporine eraClin Transplantation 4: 142-152 (1990) 14. Kozlowska-Boszko, B., Lao, M., Gaciong, Z., Sicinska, J., Durlik, M., Morzycka, M., Szmidt, J., Rowinski, W.: Chronic Rejection as a Risk Factor for Deterioration of Renal Allograft Function Following PregnancyTransplant-Proc. 29: 1522-1523 (1997) 15.Margreiter, R.: Die Entwicklung der Nierentransplantation
Nieren und Hochdruckkrankheiten32: 274-279 (2003) 16.Schmouder, R.L.: Immunsuppressive Therapies for the Twenty-First CenturyTransplant-Proc. 32: 1463-1467 (2000) 17.Tarantino, A., Montagnino, G., Cesana, B., Berardinelli, L., Passerini, P., Campise, M., Aroldi, A., Ponticelli, C.: Renal Transplantation From Older DonorsTransplant-Proc. 33: 3769-3770 (2001) 18.Friedrich, J., Albrecht, K.H., Claus, M., Eigler, F.W.: Einfluß von Spender- und Empfängeralter auf die Ergebnisse der Nierentransplantation
Dtsch-Med-Wochenschr. 14: 467-471 (1995) 19.Sancho, A., Crespo, J.F., Gorriz, J.L., Gavela, E., Cano, A., Pallardo, L.M.: Age as a Risk Factor in Renal TransplantationTransplant-Proc. 34: 355 (2002) 20.Kyllönen, L., Koskimies, S., Salmela, K.: Renal Transplant Recipients With Graft Survival Longer Than 20 Years: Report on 107 CasesTransplant-Proc. 33: 2444-2445 (2001) 21.Meier-Kriesche, H.-U., Ojo, A.O., Arndorfer, J.A., Port, F.K., Magee, J.C., Leichtmann, A.B., Punch, J.D., Kaplan, B.: Recipient Age as an Independent Risk Factor for Chronic Renal Allograft FailureTransplant-Proc. 33: 1113-1114 (2001) 22.Herrero, J.C., Gutiérrez, E., Martínez, A., González, E., Morales, E., Munoz, M.A., Valentín, M., Bueno, B., Praga, M., Hernández, E., Morales, J.M., Rodicio, J.L., Andrés, A.: Results of Kidney Transplantation in Recipients Over 70 Years of Age: Experience at a Single CenterTransplant-Proc. 35: 1675-1676 (2003) 23.Andres, A., Herrero, J.C., Gonzales, E., Morales, E., Morales, J.M., Diaz, R., Polo, G., Leiva, O., Rodicio, J.L., Praga, M .: Long-Term Results of Renal Transplantation in Elderly Cadaver Donor Recipients 65 Years Old or OlderTransplant-Proc. 34: 356-357 (2002) 24.Wilms, H., Kirste, G., Hörl, W.H., Schollmeyer, P., Farthmann, E.H.: 20 Jahre Nierentransplantation – Erfahrungen eines Klinikums
Fortschr-Med 20: 415-418 (1991) 25.Mathew, T.H., McDonald, S.P., Russ, G.R .: Donor and Recipient Risk Factors and Choice of Immunosuppression Determine Long-Term Outcome in Renal TransplantationTransplant-Proc. 33: 3400-3402 (2001) 26.Sarparanta, T., Höckerstedt, K., Ahonen, J., Eklund, B., Salmela, K., Petterson, E., Koskimies, S., von Willebrand, E.: The Effect of Long Cold Ischemia Time on Primary and Secondary Cadaver Renal AllograftsTransplant-Proc. 18: 80-83 (1986) 27.Lam, M.F., Li, F.K., Choy, B.Y., Tang, S., Lo, W.K., Lui, S.L., Chu, S.M., Tam, P.C., Chan, T.M., Lai, K.N.: The Impact of the Establishment of a Multiorgan Transplantation Program on Cold Ischemia Time and Delayed Graft Function in Renal TransplantationTransplant-Proc. 32: 1611-1612 (2000) 28.Mota, A., Figueiredo, A., Cunha, M.F.X., Bastos, M., Pratas, J., Furtado, L.: Risk Factors for Acute Rejection in 806 Cyclosporin-Treated Renal Transplants: A Multivariate AnalysisTransplant-Proc. 35: 1061-1063 (2003) 29.Degawa, H., Matsuno, N., Iwamoto, H., Hama, K., Nakamura, Y., Narumi, Y., Kikuchi, K., Uchiyama, M., Kozaki, K., Nagao, T.: Primary Nonfunctioning Grafts in Cadaveric Kidney TransplantationTransplant-Proc. 32: 1903-1904 (2000) 30.Sienko, J., Wisniewska, M., Ostrowski, M., Ciechanowski, K., Safranow, K., Chudyk, A., Fronczyk, A., Rozanski, J., Kaminski, M., Sulikowski, T., Romanowski, M., Pabisiak, K., Paczkowski, M., Mizerski, A.: Impact of Selected Factors on Early Graft Function in Patients After Renal TransplantationTransplant-Proc. 35: 2167-2169 (2003) 31.Arrazola, L., Sozen, H., Humar, A., Papalois, V., Uknis, M., Matas, A.J.: Both Immunologic and Nonimmunologic Factors are Risks for Long-Term Graft Survival – A Multivariate AnalysisTransplant-Proc. 32: 1831 (2000) 32.Sanfilippo, F., Vaughn, W.K., Bollinger, R.R., Spees, E.K.: Comparative Effects of Pregnancy, Transfusion, and prior Graft Rejection on Sensitization and Renal Transplant ResultsTransplantation 34: 360-366 (1982) 33.Iwaki, Y., Cecka, J.M., Terasaki, P.I.: The Transfusion Effect in Cadaver Kidney Transplants – Yes or NoTransplantation 49: 56-59 (1990) 34.Miura, S., Okazaki, H., Sato, T., Amada, N., Ohashi, Y., Sato, K.: Long-Term Results of Spousal Renal Donor Transplants With Donor-Specific Blood TransfusionsTransplant Proc. 33: 3417-3419 (2001) 35.Takemoto, S.K., Bradley, B.A., Gjertson, D.W., Cho, Y.W., Cecka, J.M.: Pregnancy: A Two-Edged SwordTransplant-Proc. 33: 471-472 (2001) 36.Deierhoi, M.H., Barger, B.O., Hudson, S.L., Shroyer, T.W., Diethelm, A.G.: The Effect of Erythropoietin and Blood Transfusions on Highly Sensitized Patients on a Single Cadaver Renal Allograft Waiting ListTransplantation 53: 363-368 (1992) 37.McKenna, R.M., Takemoto, S.K., Terasaki, P.I .: Anti-HLA Antibodies after solid Organ TransplantationTransplantation 69: 319-326 (2000) 38.Kokado, Y., Takahara, S., Hatori, M., Ichimaru , , I., Wang, J.D., Miki, T., Okuyama, A.: Acute Rejection Episodes Predict Long-Term Renal Transplantation SurvivalTransplant-Proc. 29: 1537-1540 (1997) 39.Castilho, C., Piovesan, F., Michelon, T., Seelig, D., Pozza, R., Santos, A.F., Bittar, A.E., Keitel, E., Goldani, J.C., Neumann, J., Garcia, V.D .: Primary Nonfunctioning Graft in Cadaveric Renal TransplantationTransplant-Proc. 33: 3785-3786 (2001) 40.Speiser, D.E., Frick, T.W., Goumaz, C., Opelz, G., Jeannet, M.: Immunologische Aspekte der Nierentransplantation in der Schweiz 1981-1992
Schweiz Med Wochenschr 125: 1573-1582 (1995) 41.Gjertson, D.W., Terasaki, P.I.: The Large Center Variation in Half-Lives of Kidney TransplantsTransplantation 53: 357-362 (1992) 42. Briganti, E.M., Wolfe, R., Russ, G.R., Eris, J.M., Walker, R.G., McNeil, J.J .: Graft loss following renal transplantation in Australia: is there a centre effect?Nephrol Dial Transplant 17: 1099-1104 (2002) 43.Kerman, R.H., Kimball, P.M., van Buren, C.T., Lewis, R.M., Kahan, B.D.: Possible Contribution of Pretransplant Immune Responder Status to Renal Allograft Survival Differences of Black versus White RecipientsTransplantation 51: 338-342 (1991) 44.Scantlebury, V., Gjertson, D., Eliasziw, M., Terasaki, P., Fung, J., Shapiro, R., Donner, A., Starzl, T.E.: Influence of HLA and CREG Matching in African-American Primary Cadaver Kidney Recipients: UNOS 1991-1995Transplant-Proc. 29: 3733-3736 (1997) 45.Opelz, G., Mytilineos, J., Scherer, S., Schwarz, V.: Clinical Implications of DNA Typing in Organ TransplantationTransplant-Proc. 29: 1524-1527 (1997) 46.Meester, J., Persijn, G., Wujciak, T., Opelz, G., Vanrenterghem, Y .: The new Eurotransplant kidney allocation SystemTransplantation 66: 1154-1159 (1998) 47.Wujciak, T., Opelz, G.: Matchability as an Important Factor for Kidney Allocation According to the HLA MatchTransplant-Proc. 29: 1403-1405 (1997) 48.Persijn, G.G., Smits, J.M.A., Smith, M., Frei, U.: Five-Year Experience With the New Eurotransplant Kidney Allocation System, 1996 to 2001Transplant-Proc. 34: 3072-3074 (2002) 49.Voiculescu, A., Ivens, K., Sandmann, W., Grabensee, B.: Lebendnierenspende und -transplantation. Hohe Transplantatüberlebensraten bei kalkulierbarem Risiko
Klinikarzt 32: 355-359 (2003) 50.Hillebrand, G.F., Theodorakis, J., Illner, W.D., Stangl, M., Ebeling, F., Gutmann, Th., Schneewind, K.A., Land, W.: Lebendspende bei Nierentransplantation – Renaissance durch nicht verwandte Spender?
MMW-Fortschr.Med. 42: 798-799 (2000) 51.Cecka, J.M., Terasaki, P.I.: Living Donor Kidney Transplants: Superior Success Rates Despite HistoincompatibilitiesTransplant-Proc. 29: 203 (1997) 52.Alfani, D., Pretagostini, R., Rossi, M., Poli, L., Bruzzone, P., Colonello, M., De Simone, P., Berloco, P., Persijn, G., Smits, J., Cortesini, R.: Living Unrelated Kidney Transplantation: A 12-Year Single Center ExperienceTransplant-Proc. 29: 191-194 (1997) 53.Duquesnoy, R.J.: HLAMatchmaker: A molecularly based Algorithm for Histocompatibility Determination. I. Description of the Algorithm.Hum-Immunol. 63: 339-352 (2002) 54.Duquesnoy, R.J., Marrari, M .: HLAMatchmaker: A molecularly based Algorithm for Histocompatibility Determination. II. Verification of the Algorithm and Determination of the relative immunogenicity of amino acid triplet-defined epitopes.Hum-Immonol. 63: 353-363 (2002) 55.Duquesnoy, R.J.: HLAMatchmaker: A Molecularly Based Donor Selection Algorithm for Highly Alloimmunized PatientsTransplant-Proc. 33: 493-497 (2001) 56.Duquesnoy, R.J.: Is Histocompatibility Testing Needed for Composite Tissue Transplantation?Transplant-Proc. 30: 2724-2728 (1998) 57.Terasaki, P.I., McClelland, J.D., Park, M.S., McCurdy, B.: Microdroplet Lymphocyte Cytotoxicity Test; In: Ray, J.G., Hare, D.B., Pedersen, P.D., Kayhoe, D.E. (Eds.)Manual of Tissue Typing Techniques. DHEW Publication no. (NIH) 75-545, p. 67-74 (1974) 58. Moldenhauer, A., Kohlhaus, R., Salama, A .: An Extended Lymphocytotoxicity Test for Patients Treated with Lymphocytotoxic AntibodiesVox-Sang. 78: 250-253 (2000) 59.Reddy, K.S., Clark, K.R., Cavanagh ,G ., Forsythe, J.L.R., Proud, G., Taylor, R.M.R.: Successfull Renal Transplantation With a Positive T-Cell Cross Match Caused by IgM AntibodiesTransplant Proc. 27: 1042-1043 (1995) 60.Wonigeit, K.: Immunsuppression bei Organtransplantation
Internist 37: 229-239 (1996) 61.May, G.: Immunsuppression und Abstoßungsbehandlung nach Nierentransplantation
Urologe 33: 365-369 (1994) 62.Kaden, J., Strobelt, V., May, G.: Short and Long-Term Results after Pretransplant High-Dose Single ATG-Fresenius Bolus in Cadaveric Kidney TransplantationTransplant-Proc. 30: 4011-4014 (1998) 63.Oesterwitz, H., May, G., Mueller, P., Strobelt, V., Seeger, W., Seibt, F., Horlbeck, R., Hansen, Ch.: Vierfach-Immunsuppression bei präsensibilisierten Patienten allogener Leichennierentransplantate
Z-Urol-Nephrol. 83: 1-8 (1990) 64.Kaden, J., Strobelt, V., Oesterwitz, H., Groth, J., May, G., Eichler, C.: Monitoring of Renal Allograft Rejection with Fine Needle Aspiration Biopsy and Serum C-Reactive Protein DeterminationsTransplant-Proc. 19: 1657 (1987) 65.Hanssen, Ch., Müller, P., Seibt, F., Oesterwitz, H., May, G., Strobelt, V., Kaden, J., Ditscherlein, G., Scholz, D.: Einsatz von OKT-3 bei der Rejektionsbehandlung nach Nierentransplantation
Z. Urol. Nephrol. 83: 165-170 (1990) 66.Rodey, G.E., Neylan, J.F., Whelchel, J.D., Revels, K.W., Bray, R.A.: Epitope Specificity of HLA Class I Alloantibodies – 1. Frequency Analysis of Antibodies to Private versus Public Specifities in Potential Transplant RecipientsHum-Immunol. 39: 272-280 (1994) 67.Brunkhorst, R., Schlitt, H.J.: Nierentransplantation – Indikationen, Ergebnisse, Vor- und Nachsorge
Internist 37: 264-271 (1996) 68.Opelz, G., Wujciak, T., Back, D., Mytilineos, J., Schwarz, V., Albrecht, G.: Einfluß der HLA-Kompatibilität auf die Nierentransplantation
Infusionsther-Transfusionsmed. 21: 198-202 (1994) 69.Opelz, G.: Factors Influencing Long-Term Graft LossTransplant-Proc. 32: 647-649 (2000) 70.Opelz, G., Wujciak, T., Döhler, B.: Is HLA Matching Worth the Effort?Transplant-Proc. 31: 717-720 (1999) 71.Opelz, G.: New Immunsuppressants and HLA MatchingTransplant-Proc. 33: 467-468 (2001) 72.Klehr, H.U., Jacobs, U., Miersch, W.D., Molitor, D.: Vergleich der Nierentransplantation mit und ohne Berücksichtigung der HLA-Typisierung
Dtsch.med.Wochenschr. 121: 434-441 (1996) 73.Klein, T., Shapira, Z., Bar Nathan, N., Shaharabani, E., Or , H., Zakai, C., Shabtei, E., Yussim, A.: Lack of Correlation Between HLA Match and Long-Term Survival in Living Donor Kidney TransplantationTransplant-Proc. 32: 692-693 (2000) 74.Hata, Y., Cecka, M., Takemoto, S., Ozawa, M., Cho, Y., Terasaki, P.I.: Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched PatientsTransplantation 65: 208-212 (1998) 75.Terasaki, P.I., Cho, Y., Takemoto, S., Cecka, M., Gjertson, D.: Twenty-Year Follow-up on the Effect of HLA Matching on Kidney Transplant Survival and Prediction of Future Twenty-Year SurvivalTransplant-Proc. 28: 1144-1145 (1996) 76.Takemoto, S., Cecka, J.M., Gjertson, D.W., Terasaki, P.I.: Six-Antigen-Matched Transplants. Causes of FailureTransplantation 55: 1005-1008 (1993) 77.Lee, P.C., Lee, P.H., Shaw, C.K., Takemoto, S.K., Gjertson, D.W., Siauw, P.A., Terasaki, P.I .: HLA Epitopes for Kidney AllocationTransplant-Proc. 30: 3496-3497 (1998) 78.Papassavas, A.C., Iniotaki-Theodoraki, A., Boletis, J., Kostakis, A., Stavropoulos-Giokas, C .: Development of Anti-HLA-Antibodies Against Intra-CREG-Mismatches in Renal Transplant RecipientsTransplant-Proc. 31: 757-759 (1999) 79.Fernandez-Fresnedo, G., Pastor, J.M., Ruiz, J.C., Cotorruelo, J.G., Setien, M.A., Lopez-Hoyos, M., Arias, M.: Differences in Anti-CREG Antibody Formation between Transplanted and Nontransplanted Renal PatientsTransplantation 67: 1188-1190 (1999) 80.Rodey, G.E., Revels, K., Fuller, T.C.: Epitope Specificity of HLA Class I Alloantibodies II. Stability of Cross-Reactive Group Antibody Patterns over extended Time PeriodsTransplantation 63: 885-893 (1997) 81.Zafar, M.N., Abbas, K., Muzaffer, R., Hafiz, S., Hussain, Z., Naqvi, A., Rizvi , S.A.: Impact of CREG Matching on Renal Allograft Survival in One Haplotype Matched TransplantsTransplant-Proc. 32: 1838 (2000) 82.Crowe, D.O.: The effect of cross-reactive epitope group matching on allocation and sensitizationClin Transplant 17 (Suppl. 9): 13-16 (2003) 83.Wujciak, T., Opelz, G.: Evaluation of HLA-Matching for CREG Antigens in EuropeTransplantation 68: 1097-1099 (1999) 84.Starzl, T.E., Eliasziw, M., Gjertson, D., Terasaki, P.I., Fung, J.J., Trucco, M., Martell, J., McMichael, J., Scantlebury, V., Shapiro, R., Donner, A .: HLA and Cross-Reactive Antigen Group Matching for Cadaver Kidney AllocationTransplantation 64: 983-991 (1997) 85.Stobbe, I., Van Der Meer-Prins, E.M.W., De Lange, P., Oudshoorn, M., De Meester, J., Doxiadis, I.I.N., Claas, F.H.J.: Cross-Reactive Group Matching does not lead to a better Allocation and Survival of Donor KidneysTransplantation 70: 157-161 (2000) 86.Thompson, J., Thacker, L., Takemoto, S.: CREG Matching for First Kidney Transplants Performed by SEOPF Centers Between October 1987 and September 1995: An Analysis of Outcome and Prospective BenefitTransplant-Proc. 29: 1435-1438 (1997) 87.Papassavas, A.C., Stavropoulos-Giokas, C., Boletis, J., Iniotaki-Theodoraki, A., Ioannou, S., Stravoskoufi, P., Kostakis, A.: Epitope Analysis of the HLA Class I Specific Antibodies: A Useful Tool for the Detection of the Acceptable Mismatches for Highly Sensitized PatientsTransplant-Proc. 34: 2053-2055 (2002) 88.Takemoto, S., Terasaki, P.I., Park, M.S., Clark, B.D.: Effect of Mismatching Serologically Defined Residues on Kidney Transplant SurvivalTransplant-Proc. 24: 1266-1268 (1992) 89.Duquesnoy, R.J., White, L.T., Iwaki, Y., Vanek, M.: Multiscreen Analysis of High PRA Sera for Antibodies Towards Public and Private Class I Antigens: Implications for Computer-Predicted Acceptable Donors for Kidney Transplant CandidatesTransplant-Proc. 23: 387-388 (1991) 90.Duquesnoy, R.J., White, L.T., Fierst, J.W., Vanek, M., Banner, B.F., Iwaki, Y., Starzl, T.E.: Multiscreen Serum Analysis of Highly Sensitized Renal Dialysis Patients for Antibodies Toward Public and Private Class I HLA DeterminantsTransplantation 50: 427-437 (1990) 91.Duquesnoy, R.J., Marrari, M.: Determination of HLA-A ,B Residue Mismatch Acceptability for Kidneys Transplanted into Highly Sensitized PatientsTransplantation 63: 1743-1751 (1997) 92.Terasaki, P.I., Takemoto, S., Park, M.S., Cecka, J.M., Mickey, M.R .: Molecular HLA MatchingTransplant-Proc. 23: 365-367 (1991) 93.Takemoto, S., Terasaki, P.I.: HLA Compatibility can be Predicted by Matching Only Three Residues with Outward Oriented SidechainsTransplant-Proc. 28: 1264-1266 (1996) 94.Adib, M., Abkar Shahnazar, E.: Evaluation of Antibody Synthesis Due to Blood Transfusion in 314 Patients From the Isfahan (Iran) Transplantation CenterTransplant-Proc. 32: 598 (2000) 95.Langer, K., Buchholz, B., Raidt, H., Graefe, U., Lison, A.-E.: Langzeitergebnisse nach Nierentransplantation
Med-Klin. 85: 637-642 (1990) 96.Terasaki, P.I., Cecka, J.M., Gjertson, D.W., Takemoto, S.: High Survival Rates of Kidney Transplants from Spousal and Living Unrelated DonorsN-Engl-J-Med. 333: 333-336 (1995) 97.Opelz, G., Vanrenterghem, Y., Kirste, G., Gray, D.W.R., Horsburgh, T., Lachance, J.-G., Largiader, F., Lange, H., Vujaklija-Stipanovic, K., Alvarez-Grande, J., Schott, W., Hoyer, J., Schnuelle, P., Descoeudres, C., Ruder, H., Wujciak, T., Schwarz, V.: Prospective Evaluation of Pretransplant Blood Transfusions in Cadaver Kidney RecipientsTransplantation 63: 964-967 (1997) 98.Hardy, M.A., Reed, E., Suciu-Foca, N.: Antiidiotypic antibodies and pretreatment with blood transfusions in organ transplantationClin Transplantation (Spec. issue) 5: 501-504 (1991) 99.Dewar, P.J., Murray, S., Wilkinson, R., Elliott, R.W., Ward, M.K., Proud, G., Taylor, R.M.R .: A New Finding Relating to Transfusion and Renal TransplantsTransplantation 29: 379-380 (1980) 100.Heise, E.R., Thacker, L.R., MacQueen, J.M., Peters, T.G .: Repeated HLA mismatches and second renal graft survival in centers of the South-eastern Organ Procurement FoundationClin Transplantation 10: 579-585 (1996) 101.Mariat, C., Alamartine, E., De Filippis, J.P., Deprele, C., Le Petit, J.C., Goure, D., Berthoux, F.: Effect of HLA Semi-Identical Pretransplant Blood Transfusion on Renal Allograft OutcomeTransplant-Proc. 32: 381-383 (2000) 102.Fernandez-Fresnedo, G., Pastor, J.M., Lopez-Hoyos, M., Ruiz, J.C., Zubimendi, J.A., Gonzalez-Cotorruelo, J., Rodrigo, E., De Francisco, A.L.M., Arias, M.: Relationship of donor-specific class-I anti-HLA antibodies detected by ELISA after kidney transplantation on the development of acute rejection and graft survivalNephrol Dial Transplant 18: 990-995 (2003) 103.Doxiadis, I.I.N., de Lange, P., D´Amaro, J., de Meester, J., Schreuder, G.M.T., Claas, F.H.J .: Repeated HLA Mismatches in Cadaveric Renal Transplantation: Is It Safe to Transplant?Transplant-Proc. 29: 1408-1409 (1997) 104.Coupel, S., Giral-Classe, M., Karam, G., Morcet, J.F., Dantal, J., Cantarovich, D., Blancho, G., Bignon, J.D., Daguin, P., Soulillou, J.P., Hourmant, M.: Ten-year survival of second kidney transplants : Impact of immunologic factors and renal function at 12 monthsKidney Int64: 674-680 (2003) 105.Opelz, G., Terasaki, P.I .: Second Kidney Transplants and PresensitizationTransplant-Proc. 4: 743-748 (1972) 106.Arndorfer, J.A., Meier-Kriesche, H.U., Ojo, A.O., Gruber, S.A., Cibrik, D.M., Lake, K.D., Kaplan, B., Leichtman, A.B.: Time to First Graft Loss as a Risk Factor for Second Renal Allograft LossTransplant-Proc. 33: 1188-1189 (2001) 107.Nanri ,., Tanabe, K., Ishida, H., Tokumoto, T., Shinmura, H., Toma, H.: Poor Graft Survival in Patients Historically Positive for Antidonor Antibody After Living Related Renal TransplantationTransplant-Proc. 34: 1583 (2002) 108.Torrecilhas, A.C.T., Medina, J.O.P., Panajotopoulos, N., Moura, L.A.R., Gerbase-DeLima, M .: Detection and Clinical Significance of Lymphocytotoxic Antibodies Following Renal TransplantationTransplant-Proc. 34: 482-483 (2002) 109.Worthington, J.E., Martin, S., Dyer, P.A., Johnson, R.W.G .: An Association Between Posttransplant Antibody Production and Renal Transplant RejectionTransplant-Proc. 33: 475-476 (2001) 110.Piazza, A., Poggi, E., Borrelli, L., Valeri, M., Buonomo, O., Servetti, S., Adorno, D., Casciani, C.U .: Relevance of Posttransplant HLA Class I and Class II Antibodies on Renal Graft OutcomeTransplant-Proc. 33: 478-480 (2001) 111.Goulmy, E., Stijnen, T., Groenewoud, A.F., Persijn, G.G., Blokland, E., Pool, J., Paul, L.C., Van Rood, J.J.: Renal Transplant Patients Monitored by the Cell-Mediated Lympholysis AssayTransplantation 48: 559-563 (1989) 112.Schönemann, C., Groth, J., Leverenz, S., May, G.: HLA Class I and II Antibodies – Monitoring Before and After Kidney Transplantation and Their Clinical RelevanceTransplantation 65: 1519-1522 (1998) 113.Suberbielle-Boissel, C., Legendre, C., Meunier, D., Kreis, H., Charron, D., Raffoux, C.: Anti-HLA Sensitization Against Graft Specificities After Kidney Transplantation : Use of PRA-Stat ELISATransplant-Proc. 32: 418 (2000) 114.Norman, P.J., Harmer, A.W., Koffman, C.G., Vaughan, R.W.: Presence of IgG HLA Antibodies in Patients with Long-Surviving Renal AllograftsTransplant-Proc. 27: 999-1000 (1995) 115.Christiaans, M., van den Berg-Loonen, E., Ten Haaft, A., Nieman, F., van Hooff, J.: Effect of Flow Cytometry, Complement-Dependent Cytotoxicity, and Auto Cross Match on Cadaveric Renal Transplant OutcomeTransplant-Proc. 27: 1028-1030 (1995) 116.Vaidya, S., Orchard, P., Haneke, R., Fish, J .: Primary Nonfunction and Preformed Anti-HLA AntibodiesTransplant-Proc. 27: 1033-1035 (1995) 117.Guttmann, R.D.: Delayed Graft Function, Rejection, and Long-Term PrognosisTransplant-Proc. 32: 1453 (2000) 118.Smit, J.A., Stark, J.H., Margolius, L., Thomson, P., Botha, J.R., Meyers, A.M., Myburgh, J.A.: Preformed Antibodies in Predicting Clinical Renal Graft OutcomeTransplant-Proc. 23: 413-414 (1991) 119.Kandaswamy, R., Gillingham, K., Humar, A., Payne, W.D., Dunn, D.L., Sutherland, D.E.R., Najarian, J.S., Matas, A.J.: Impact of HLA-ABDR Match on Chronic Rejection in Kidney TransplantsTransplant-Proc. 33: 1292 (2001) 120.Kandaswamy, R., Humar, A., Payne, W.D., Dunn, D.L., Sutherland, D.E.R., Matas, A.J.: Risk Factors for Kidney Transplant Acute Rejection: A Multivariate AnalysisTransplant-Proc. 33: 1112 (2001) 121.Mota, A., Figueiredo, A., Macario, F., Cunha, F.X., Freitas, L., Parada, B., Bastos, C., Furtado, L .: Risk Factors for Chronic Graft Dysfunction in 918 Renal TransplantsTransplant-Proc. 35: 1064-1065 (2003) 122.Fernandez-Fresnedo, G., Pastor, J.M., Lopez-Hoyos, M., de Francisco, A.L.M., Rodrigo, E., Cotorruelo, J.G., Zubimendi, J.A., Ruiz, J.C., Pinera, C., Herraez, I., Arias, M.: Clinical Relevance of Posttransplantation HLA Antibody Monitoring by ELISATransplant-Proc. 35: 701 (2003) 123.Al-Hussein, K.A.., Shenton, B.K., Bell, A., Talbot, D., Clark, K.R., Rigg, K.M., Forsythe, J.L.R., Proud, G., Taylor, R.M.R.: Characterization of donor-directed antibody class in the post-transplant period using flow cytometry in renal transplantationTranspl Int. 7: 182-189 (1994) 124.Sengar, D.P.S., Couture, R.A., Bell, R.C., Lazarovits, A.I., Jindal, S.L.: Deleterious effect of T- and B-cell panel antibodies and donor-specific B-cell crossmatches on cadaveric renal allograft survivalClin Transplantation 4: 112-116 (1990) 125.Kerman, R.H., Susskind, B., Buelow, R., Regan, J., Pouletty, P., Williams, J., Gerolami, K., Kerman, D.H., Katz, S.M., Van Buren, C.T., Kahan, B.D.: Correlation of ELISA-Detected IgG and IgA Anti-HLA Antibodies in Pretransplant sera with renal allograft RejectionTransplantation 62: 201-205 (1996) 126.Lavee, J., Kormos, R.L., Duquesnoy, R.J., Zerbe, T.R., Armitage, J.M., Vanek, M., Hardesty, R.L., Griffith, B.P.: Influence of Panel-reactive Antibody and Lymphocytotoxic Crossmatch on Survival after Heart TransplantationJ-Heart-Lung-Transplant. 6: 921-929 (1991) 127.Monteiro, F., Mineiro, C., Rodrigues, H., de Paula, F.J., Kalil, J.: Pretransplant and Posttransplant Monitoring of Anti-HLA Class I IgG1 Antibodies by ELISA Identifies Patients at High Risk of Graft LossTransplant-Proc. 29: 1433-1434 (1997) 128.Süsal, C., Opelz, G.: Kidney Graft Failure and Presensitization against HLA Class I and Class II AntigensTransplantation 73: 1269-1273 (2002) 129.Piazza, A., Torlone, N., Valeri, M., Poggi, E., Monaco, P.I., Provenzani, L., Tisone, G., Adorno, D., Casciani, C.U .: Antidonor-HLA Antibodies and Soluble HLA Antigens after Kidney TransplantTransplant-Proc. 25: 3279-3280 (1993) 130.Buchler, M., Al Najjar, A., Guerraoui, A., Valentin, J.F., Boulanger, M.D., Sherobeen, R., Lataste, A., Nivet, H., Lebranchu, Y.: Posttransplant Anti-HLA Antibodies: Risk Factor for Chronic RejectionTransplant-Proc. 27: 2478-2479 (1995) 131.Barr, M.L., Cohen, D.J., Benvenisty, A.I., Hardy, M., Reemtsma, K., Rose, E.A., Marboe, C.C., D´Agati, V., Suciu-Foca, N., Reed, E .: Effect of Anti-HLA Antibodies on the Long-Term Survival of Heart and Kidney AllograftsTransplant-Proc. 25: 262-264 (1993) 132.Kerman, R.H., Susskind, B., Kerman, D.H., Lam, M., Gerolami, K., Williams, J., Kalish, R., Campbell, M., Katz, S.M., Van Buren, C.T., Kahan, B.D.: Anti-HLA Antibodies Detected in Posttransplant Renal Allograft Recipient Sera Correlate with Chronic RejectionTransplant-Proc. 29: 1515-1516 (1997) 133.Deka, R., Panigrahi, A., Aggarwal, S.K., Guleria, S., Dash, S.C., Mehta, S.N., Pandey, R.M., Mehra, N.K .: Influence of Pretransplant Panel Reactive Antibodies on the Posttransplant Sensitization StatusTransplant-Proc. 34: 3082-3083 (2002) 134.Lobo, P.I., Spencer, C., Douglas, M.T., Stevenson, W.C., Pruett, T.L.: The Lack of Long-Term Detrimental Effects on Liver Allografts Caused by Donor-Specific Anti-HLA AntibodiesTransplantation 55: 1063-1066 (1993) 135.Groth, J., Knijnenburg, C., Kaden, J., Strobelt, V., May, G.: Serologische Untersuchungen an Patienten mit frühem Transplantatversagen
Z Urol Nephrol 79: 405-409 (1986) 136.Leverenz, S., Krause, I.K., Schönemann, C., Schirmer, R., Strobelt, V., May, G.: Bewertung der HLA-Kompatibilität bei Nierentransplantation unter Berücksichtigung des Auftretens lymphozytotoxischer HLA-Antikörper nach Bluttransfusionen und Transplantationen
Tx Med 8: 54-66 (1996) 137.Lamm, L.U., Graugaard, B., Kissmeyer, F .: Kidney Transplantation in Highly Sensitized PatientsTransplant-Proc. 18: 18-19 (1986) 138.Ogura, K., Terasaki, P.I., Johnson, C., Mendez, R., Rosenthal, J.T., Ettenger, R., Martin, D.C., Dainko, E., Cohen, L., Mackett, T., Berne, T., Barba, L., Liebermann, E.: The Significance of a Positive Flow Cytometry Crossmatch Test in primary Kidney TransplantationTransplantation 56: 294-298 (1993) 139.Terasaki, P.I., Takemoto, S., Park, M.S., Clark, B .: Landsteiner Award. HLA epitope matchingTransfusion 32: 775-786 (1992) 140.Martin, S., Conolly, J., Jos, V.: Importance of HLA Matching in Highly Sensitised Renal Transplant Recipients with High Transplant Survival RatesTransplant-Proc. 25: 265-266 (1993) 141.Ghobrial, I.I., Morris, A.G., Booth, L.J .: Clinical significance of in vitro donor-specific hyporesponsiveness in renal allograft recipients as demonstrated by the MLRTranspl Int 7: 420-427 (1994) 142.Reinsmoen, N.L., Hertz, M.I., Kubo, S., Bolman, R.M., Matas, A.J.: Immun Factors Correlating with Improved Long-Term Graft Outcome in Kidney, Lung, and Heart TransplantsTransplant-Proc. 25: 3277-3278 (1993) 143.Reinsmoen, N.L., Matas, A.J .: Evidence that improved Late Renal Transplant Outcome Correlates with the Development of In Vitro Donor Antigen-Specific HyporeactivityTransplantation 55: 1017-1023 (1993) 144.Kerman, R.H., Katz, S.M., Schoenberg, L., Baraket, O., Van Buren, C.T., Kahan, B.D.: Ten-Year Follow-Up of Mixed Lymphocyte Reaction-Hyporesponsive Living Related Cyclosporine Monotherapy-Treated Renal Allograft RecipientsTransplant-Proc. 29: 198-199 (1997) 145.Knoop, M., Neumann, U., Neuhaus, P.: Immunologische Toleranz nach experimenteller Lebertransplantation
Langenbecks Arch Chir380: 281-287 (1995) 146.Lantz, O., Alard, P., Ben Aribia, M.H., Chavanel, G., Fries, D., Senik, A., Charpentier, B.: Persistence of Donor-Specific IL-2-Secreting Cells and Cytotoxic T Lymphocyte Precursors in Human Kidney Transplant Recipients Evidenced by Limiting Dilution AnalysisJ-Immunol. 144: 3748-3755 (1990) 147.Yang, L., DuTemple, B., Khan, Q., Zhang, L .: Mechanisms of Long-Term Donor-Specific Allograft Survival Induced by Pretransplant Infusion of LymphocytesBlood 91: 324-330 (1998) 148.Kerman, R.H., Susskind, B., Katz, S.M., Van Buren, C.T., Kahan, B.D .: Postrenal Transplant MLR Hypo-Responders Have Fewer Rejections and Better Graft Survival Than MLR Hyper-RespondersTransplant-Proc. 29: 1410-1411 (1997) 149.Propper, D.J., Stewart, K.N., Catto, G.R.D., MacLeod, A.M., Power, D.A.: Relative Effects of Major and Minor Histocompatibility Locus Antigens on the Generation of Suppressor Activity by Blood TransfusionsTransplant-Proc. 23: 437-440 (1991) 150.Kahan, B.D., Kerman, R.H., Van Buren, C.T., Flechner, S.M., Golden, D.L., Lewis, R.M.: Clinical Outcome in 36 Patients after at least One up to 5 Years of Steroid Withdrawal Based upon Specific Mixed Lymphocyte Reaction Hyporesponsiveness Toward the Living Related DonorTransplant-Proc. 21: 1579-1580 (1989)